DCOY Stock Catalyst: Decoy Therapeutics Announces Breakthrough in vitro Activity Against Ebola Zaire

Jul 27, 2026 · 9:00am ET

Expands D-MAV™ Platform into High Consequence Global Health Threats

Max move

+69.8%

High of day $8.49

Sparker timei

9:00am ET

DCOY · Jul 27, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Decoy Therapeutics Inc. (Nasdaq: DCOY) announced a significant breakthrough in its D-MAV™ Platform, demonstrating in vitro activity against Ebola Zaire. This development marks an important expansion of the platform's capabilities into addressing high consequence global health threats.

The announcement highlights Decoy Therapeutics' ongoing efforts to leverage its innovative technology to combat some of the world's most dangerous pathogens. The company's free float stands at 528,860 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time DCOY sparks.

Download Sniper App →

Catch the next DCOY-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →